The Cigna Group (NYSE:CI – Get Free Report) announced its quarterly earnings data on Thursday. The health services provider reported $6.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.17 by $0.30, Briefing.com reports. The business had revenue of $57.25 billion during the quarter, compared to analysts’ expectations of $56.59 billion. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The firm’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.41 earnings per share. The Cigna Group updated its FY24 guidance to at least $28.40 EPS.
The Cigna Group Stock Performance
CI traded down $3.05 during trading on Friday, hitting $341.45. The company’s stock had a trading volume of 2,413,542 shares, compared to its average volume of 1,593,263. The Cigna Group has a one year low of $240.50 and a one year high of $365.71. The business’s 50 day simple moving average is $350.82 and its 200-day simple moving average is $319.39. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.61. The firm has a market cap of $99.82 billion, a PE ratio of 19.63, a P/E/G ratio of 1.09 and a beta of 0.57.
The Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th will be issued a dividend of $1.40 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.64%. The Cigna Group’s dividend payout ratio is currently 32.20%.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on CI
Insider Transactions at The Cigna Group
In related news, CEO David Cordani sold 38,065 shares of The Cigna Group stock in a transaction on Friday, February 9th. The stock was sold at an average price of $335.22, for a total transaction of $12,760,149.30. Following the transaction, the chief executive officer now directly owns 329,321 shares in the company, valued at $110,394,985.62. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the firm’s stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the sale, the senior vice president now directly owns 2,102 shares in the company, valued at approximately $694,668.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David Cordani sold 38,065 shares of the firm’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $335.22, for a total value of $12,760,149.30. Following the sale, the chief executive officer now directly owns 329,321 shares in the company, valued at $110,394,985.62. The disclosure for this sale can be found here. Insiders sold 114,144 shares of company stock worth $39,296,330 in the last three months. Corporate insiders own 0.60% of the company’s stock.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Five stocks we like better than The Cigna Group
- How to Buy Cheap Stocks Step by Step
- Appleās Earnings Show Investors Its Strength and Its Weakness
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- 3 Warren Buffett Stocks to Buy Now
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.